Financhill
Back

Adaptive Biotechnologies Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
38

ADPT
Adaptive Biotechnologies

Last Price:
4.67
Seasonality Move:
-1.77%
Sell
30

NBY
NovaBay Pharmaceuticals

Last Price:
0.70
Seasonality Move:
-0.57%
Sell
38
Adaptive Biotechnologies (ADPT) is a Sell

Is Adaptive Biotechnologies a Buy, Sell or Hold?

  • The current Adaptive Biotechnologies [ADPT] share price is $4.68. The Score for ADPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ADPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.70. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADPT Stock Price Chart

What is Adaptive Biotechnologies's stock price today?

  • The Adaptive Biotechnologies share price today is $4.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADPT is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.70
    The current trend is relatively stagnant and NBY is experiencing slight selling pressure.

ADPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.15 Buy
Relative Strength Index (14 RSI): 41.81 Sell
Chaikin Money Flow: -1263705 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.6 - 5.68) Sell
Bollinger Bands (100): (4.03 - 5.19) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 51.73 Buy
Chaikin Money Flow: -26155 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.74) Buy
Bollinger Bands (100): (0.28 - 1.54) Sell

ADPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.63 Sell
20-day SMA: 5.23 Sell
50-day SMA: 4.95 Sell
200-day SMA: 3.98 Buy
8-day EMA: 5.38 Sell
20-day EMA: 5.31 Sell
50-day EMA: 5.01 Sell
200-day EMA: 4.56 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.68 Buy
50-day SMA: 0.64 Buy
200-day SMA: 2.41 Sell
8-day EMA: 0.71 Sell
20-day EMA: 0.7 Buy
50-day EMA: 0.74 Sell
200-day EMA: 5.77 Sell

Adaptive Biotechnologies Earnings Growth & ADPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.26 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Adaptive Biotechnologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):